Sanofi (France)'s MS Drugs Get Double Boost in Europe

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sanofi's hopes in the multiple sclerosis market received a double boost on Friday as the European regulator backed an injectable treatment and adopted a more positive stance toward a pill for the neurodegenerative disease.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC